Enhancing oncolytic virotherapy: observations from a Voronoi cell-based model

DOI10.1016/J.JTBI.2019.110052MaRDI QIDQ2335387zbMATH OpenOpenAlexWikidataFDO

Authors Adrianne L. Jenner, Federico Frascoli, Adelle C. F. Coster, Peter S. Kim

Publication date 14 November 2019

Published in Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1016/j.jtbi.2019.110052

zbMATH Keywords

agent-based modelcell-based modelcellular automatonmathematical modellingoncolytic virustumourVoronoi tessellation

Mathematics Subject Classification ID

Medical applications (general) (92C50)

Recommendations

• Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols
• Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics
• Application of control theory in a delayed-infection and immune-evading oncolytic virotherapy
• The role of viral infectivity in oncolytic virotherapy outcomes: a mathematical study
• scientific article; zbMATH DE number 6720796

Cites work

• A Pearson random walk with steps of uniform orientation and Dirichlet distributed lengths
• scientific article; zbMATH DE number 431863 (Why is no real title available?)
• Mathematical modeling of cancer radiovirotherapy
• Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols
• Modeling multiple infection of cells by viruses: challenges and insights
• Modelling heterogeneity in viral-tumour dynamics: the effects of gene-attenuation on viral characteristics
• ODE models for oncolytic virus dynamics
• Solving multidimensional fractional Fokker-Planck equations via unbiased density formulas for anomalous diffusion processes
• The influence of turning angles on the success of non-oriented animal searches

Cited in

(13)

• The replicability of oncolytic virus: defining conditions in tumor virotherapy
• A single-cell mathematical model of SARS-CoV-2 induced pyroptosis and the effects of anti-inflammatory intervention
• The role of viral infectivity in oncolytic virotherapy outcomes: a mathematical study
• Control exponential growth of tumor cells with slow spread of oncolytic virus
• Oncolytic virus treatment of human breast cancer cells: modelling therapy efficacy
• Computational modeling approaches to studying the dynamics of oncolytic viruses
• Oscillation thresholds via the novel MBR method with application to oncolytic virotherapy
• Agent-based and continuum models for spatial dynamics of infection by oncolytic viruses
• Calibration of agent based models for monophasic and biphasic tumour growth using approximate Bayesian computation
• A phenotype-structured mathematical model for the influence of hypoxia on oncolytic virotherapy
• Being Bayesian in the 2020s: opportunities and challenges in the practice of modern applied Bayesian statistics
• Dynamics of cytotoxic and helper T cell interactions in the tumor microenvironment under oncolytic virotherapy
• Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics

Describes a project that uses

Uses Software

• PhysiCell

This page was built for publication: Enhancing oncolytic virotherapy: observations from a Voronoi cell-based model

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2335387)